12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Monday's intraday session, several healthcare stocks experienced significant movements. EyePoint Pharmaceuticals (EYPT) saw a substantial increase of 172.8%, while Alterity Therapeutics (ATHE) and Altimmune (ALT) also had notable gains. Conversely, NexImmune (NEXI), BioAtla (BCAB), and Vivos Therapeutics (VVOS) were among the stocks that declined.
December 04, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BioAtla stock decreased by 20.63% to $1.41, with a market cap of $67.3 million.
The significant drop in price reflects bearish investor sentiment, which could lead to further short-term declines as investors may exit their positions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
NexImmune shares fell 33.7% to $4.01, with a market cap of $4.2 million.
A sharp decline in stock price can lead to negative sentiment and potential further short-term drops as investors may continue to sell off.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Vivos Therapeutics shares dropped 20.22% to $15.88, with a market cap of $21.1 million.
A substantial decrease in stock price could indicate a negative outlook from investors, potentially leading to further short-term depreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Altimmune shares increased by 34.98% to $4.82, with a market cap of $258.9 million.
A significant rise in stock price often leads to continued investor interest, which may result in further short-term appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Alterity Therapeutics stock jumped 122.28% to $3.69, with a market cap of $15.0 million.
The triple-digit percentage increase is a bullish signal that could attract more investors and potentially lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
EyePoint Pharmaceuticals stock soared 172.8% to $18.03, with a market cap of $636.6 million.
The significant surge in stock price indicates strong investor interest and positive sentiment, which could lead to continued short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100